Class I Recall for 350,000 Medtronic Defibrillators: FDA Posted on July 19th, 2023 by LEADconnection Post navigation Previous: Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation (HEAL)Next: Preclinical cardiac perforation reduction in leadless pacing: Anupdate to the Micra leadless pacemaker delivery system
REACT DX Registry Highlights Relevance of Atrial High-Rate Episode Remote Monitoring in ICD Patients Posted on July 13th, 2023 by LEADconnection Post navigation Previous: First Dual-Chamber Leadless Pacemaker Surpasses Safety and Performance Goals at 90 DaysNext: 2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic
First Dual-Chamber Leadless Pacemaker Surpasses Safety and Performance Goals at 90 Days Posted on July 11th, 2023 by LEADconnection Post navigation Previous: Clinical predictors of incomplete coronary sinus lead removal during transvenous lead extraction in patients with cardiac resynchronization therapyNext: REACT DX Registry Highlights Relevance of Atrial High-Rate Episode Remote Monitoring in ICD Patients